HPSE and cancer: Heparin mimetics designed for specific targets are expected to act preferentially on specific proteins such as growth factors of the FGF family and VEGF, and heparanase, which are overexpressed in cancer, but as was seen with PG545 other activities may well be detected for some of these compounds.